Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine

Area of Science:

• Dermatology
• Immunology
• Infectious Diseases

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths globally.
• Vaccine development offers hope for pandemic control, but vaccine hesitancy due to concerns about adverse reactions remains a significant challenge.
• Clear documentation of vaccine side effects is crucial for public trust and vaccine acceptance.

Observation:

• A case report focusing on a female patient who experienced dermatological adverse events following vaccination.
• The patient developed acral petechiae, desquamation of the fingers, and a facial rash.
• These symptoms appeared shortly after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine.

Findings:

• The case highlights specific cutaneous manifestations potentially associated with the Pfizer-BioNTech COVID-19 vaccine.
• The described symptoms include petechiae on the extremities and peeling of the skin on the fingers, along with a facial rash.
• This documentation contributes to the understanding of rare adverse reactions to SARS-CoV-2 vaccines.

Implications:

• Understanding and transparently reporting vaccine side effects can help address vaccine hesitancy.
• This case provides valuable clinical information for healthcare providers managing patients with post-vaccination dermatological symptoms.
• Further research into the mechanisms and prevalence of such reactions is warranted to ensure vaccine safety and efficacy.